Insulin Degludec in Type 1 Diabetes: A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine

OBJECTIVE: Insulin degludec (IDeg) is a basal insulin that forms soluble multihexamers after subcutaneous injection, resulting in an ultra-long action profile. We assessed the efficacy and safety of IDeg formulations administered once daily in combination with mealtime insulin aspart in people with...

Descripción completa

Detalles Bibliográficos
Autores principales: Birkeland, Kåre I., Home, Philip D., Wendisch, Ulrich, Ratner, Robert E., Johansen, Thue, Endahl, Lars A., Lyby, Karsten, Jendle, Johan H., Roberts, Anthony P., DeVries, J. Hans, Meneghini, Luigi F.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041203/
https://www.ncbi.nlm.nih.gov/pubmed/21270174
http://dx.doi.org/10.2337/dc10-1925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041203/
https://www.ncbi.nlm.nih.gov/pubmed/21270174
http://dx.doi.org/10.2337/dc10-1925

Ejemplares similares